NCT00423059View on ClinicalTrials.gov

Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2006

Study Completion Date

March 31, 2007

Conditions
Diabetic Retinopathy
Interventions
DRUG

bevacizumab

Trial Locations (1)

120-752

Department of Ophthalmology, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT00423059 - Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy | Biotech Hunter | Biotech Hunter